{"id":767808,"date":"2023-07-05T12:27:57","date_gmt":"2023-07-05T16:27:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/"},"modified":"2023-07-05T12:27:57","modified_gmt":"2023-07-05T16:27:57","slug":"immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/","title":{"rendered":"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, July  05, 2023  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio,\u201d\u202for the \u201cCompany\u201d) (NASDAQ: IBRX). The lawsuit alleges ImmunityBio made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects, including: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, good manufacturing practice (\u201cGMP\u201d) deficiencies at its third-party contract manufacturing organizations (\u201cCMOs\u201d) for its product, Anktiva; (ii) one or more of the Company\u2019s third-party CMOs for Anktiva did in fact suffer from GMP deficiencies; (iii) the foregoing deficiencies were likely to cause the FDA to reject the Anktiva Biologics License Application in its present form; and (iv) accordingly, the Company overstated the regulatory approval prospects for the Anktiva BLA.<\/p>\n<p align=\"justify\">If you bought shares of ImmunityBio between May 23, 2022 and May 10, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CTpFA-XVZvez5t7TwQODJ5YMjL1mfuH0T0PNwvG_UnuPQbsXgga5RcPAYYoTvZ_JA3Q-6ijcE_r_YRH5XmrciHMN8IwrKFy45f0FW0nq8Q8=\" rel=\"nofollow noopener\" target=\"_blank\">cholzer@holzerlaw.com<\/a> or Joshua Karr, Esq. at\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jWBl3mQ2I9112LrmBOLkSuoKECrq6vbteOsToOK6B60azsZHrc5GhWqr5dtQKLBM3OnpFsIUFlfM1WyXYYF8zsZNUdjdQHIqosRUONs-Hng=\" rel=\"nofollow noopener\" target=\"_blank\">jkarr@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4ZL1NWc-PrEoFl4v1xtEpDuw9Vcap3t1iZ77_UFd39M4311QsMCjqZUogLf6ZCLXKIf1Wo1bmqUySxUd79tCmDDEcnh-CSKWvGC6YVCk1INy5yUiOq_B0ku5KLnM_yyoJ7qvUfq2h-j5ENZp8LXXCg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.holzerlaw.com\/case\/immunitybio\/<\/u><\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is August 29, 2023. <\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4ZL1NWc-PrEoFl4v1xtEpLlAe5sJ9Q5gd882VRYdF69eFqCiTB1rtTANj8hLO38wz8_krtGLVF_SOhTPlWHPxiP3W3AiaBi31YlDnBqpUkk=\" rel=\"nofollow noopener\" target=\"_blank\">www.holzerlaw.com<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CTpFA-XVZvez5t7TwQODJ5YMjL1mfuH0T0PNwvG_Unugi_b9yOsC7t5qX1iXYhSOfGEteBGs-hDphQ0v2JzPvQ0zwUUtifFaVPEzCMh36XA=\" rel=\"nofollow noopener\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NzYzYzQ1Y2ItZmFmZS00MjBmLTg3YTMtMTdhNTlmYTUxODAxLTExOTIzMzY=\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, July 05, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio,\u201d\u202for the \u201cCompany\u201d) (NASDAQ: IBRX). The lawsuit alleges ImmunityBio made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects, including: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, good manufacturing practice (\u201cGMP\u201d) deficiencies at its third-party contract manufacturing organizations (\u201cCMOs\u201d) for its product, Anktiva; (ii) one or more of the Company\u2019s third-party CMOs for Anktiva did in fact suffer from GMP deficiencies; (iii) the foregoing deficiencies were likely to cause the FDA to reject the Anktiva Biologics License Application in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-767808","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, July 05, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio,\u201d\u202for the \u201cCompany\u201d) (NASDAQ: IBRX). The lawsuit alleges ImmunityBio made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects, including: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, good manufacturing practice (\u201cGMP\u201d) deficiencies at its third-party contract manufacturing organizations (\u201cCMOs\u201d) for its product, Anktiva; (ii) one or more of the Company\u2019s third-party CMOs for Anktiva did in fact suffer from GMP deficiencies; (iii) the foregoing deficiencies were likely to cause the FDA to reject the Anktiva Biologics License Application in &hellip; Continue reading &quot;ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-05T16:27:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm\",\"datePublished\":\"2023-07-05T16:27:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/\",\"name\":\"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=\",\"datePublished\":\"2023-07-05T16:27:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/","og_locale":"en_US","og_type":"article","og_title":"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","og_description":"ATLANTA, July 05, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio,\u201d\u202for the \u201cCompany\u201d) (NASDAQ: IBRX). The lawsuit alleges ImmunityBio made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects, including: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, good manufacturing practice (\u201cGMP\u201d) deficiencies at its third-party contract manufacturing organizations (\u201cCMOs\u201d) for its product, Anktiva; (ii) one or more of the Company\u2019s third-party CMOs for Anktiva did in fact suffer from GMP deficiencies; (iii) the foregoing deficiencies were likely to cause the FDA to reject the Anktiva Biologics License Application in &hellip; Continue reading \"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-05T16:27:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm","datePublished":"2023-07-05T16:27:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/","name":"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=","datePublished":"2023-07-05T16:27:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2OTQzOSM1Njc4MzkyIzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunitybio-inc-ibrx-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant-losses-t\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImmunityBio, Inc. (IBRX) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/767808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=767808"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/767808\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=767808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=767808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=767808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}